Morning Overview on MSN
Flash radiotherapy aims to deliver 10+ Gy in 0.1 seconds to spare tissue
Researchers are testing a radiation technique that compresses an entire cancer treatment dose into a fraction of a second, ...
What: On today, February 23, 2026, the Maryland Proton Treatment Center (MPTC) will celebrate a momentous milestone – fighting cancer for +10 years with proton therapy. To commemorate this occasion, ...
Hodgkin lymphoma and primary mediastinal B-cell lymphoma are two aggressive blood cancers that affect young people between their late teens and mid-30s, a group often referred to as Adolescents and ...
bDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA cDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA dDepartment of Surgery, ...
A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results. “Very ...
1 Department of Radiation Oncology, MedStar Georgetown University Hospital, Washington, USA. 2 Department of Radiation Oncology, Johns Hopkins University, Baltimore, USA. As with IMRT, ...
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT. RADIATION THERAPY IS A COMMON TREATMENT FOR CANCER. ABOUT HALF OF ALL CANCER PATIENTS WILL RECEIVE IT. ONE OF THE DOWNSIDES OF TRADITIONAL RADIATION IS THAT ...
Add Yahoo as a preferred source to see more of our stories on Google. A different kind of radiation therapy can help cancer patients preserve who they are. About half of all cancer patients typically ...
ABSTRACT: Purpose: To introduce a knowledge-based planning (KBP) framework for intensity-modulated proton therapy (IMPT) that generates patient-specific dose-volume histogram (DVH) objectives using a ...
Southwest Florida Proton has introduced a new machine for fighting cancer. The IBA ProteusONE uses proton therapy to target cancerous tissue. This technology is designed to spare healthy tissue and ...
In a phase 3 trial of patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) resulted in noninferior progression-free survival and better overall survival than ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new center offering treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results